Related Experiment Video
Updated: Jun 5, 2026

A Preclinical Model of Sepsis-Induced Myopathy with Disuse in Mice
Published on: June 14, 2024
Skeletal muscle dysfunction in critical care: wasting, weakness, and rehabilitation strategies
Zudin Puthucheary1, Stephen Harridge, Nicholas Hart
1Lane Fox Respiratory Unit, Guy's and St Thomas' Foundation Trust and Kings College, London, UK.
Abstract:
Understanding the trajectory of skeletal muscle loss, evaluating its relationship to the subsequent functional impairment, and understanding the underlying mechanisms of skeletal muscle wasting will provide goals for novel treatment strategies in the intensive care setting. A focused approach on the effect of critical illness on muscle morphology, muscle protein turnover, and the associated muscle-signaling pathways during the early and recovery stages of critical illness is required. This could potentially lead to targeted pharmacologic and nonpharmacologic strategies to treat, or even prevent, peripheral muscle wasting and weakness.
Insights
Critical illness causes skeletal muscle wasting and functional impairment. Understanding these effects and mechanisms can guide new treatments to prevent muscle loss in intensive care patients.
Area of Science:
- Critical care medicine
- Muscle physiology
- Pathophysiology
Background:
- Skeletal muscle wasting is a common complication in critically ill patients.
- This muscle loss leads to significant functional impairment and prolonged recovery.
- The underlying mechanisms of muscle wasting during critical illness are not fully understood.
Purpose of the Study:
- To investigate the trajectory of skeletal muscle loss in critical illness.
- To evaluate the relationship between muscle wasting and functional impairment.
- To elucidate the mechanisms of muscle wasting in early and recovery stages of critical illness.
Main Methods:
- Focused examination of muscle morphology.
- Analysis of muscle protein turnover.
- Investigation of associated muscle-signaling pathways.
Main Results:
- Critical illness significantly impacts muscle morphology and protein dynamics.
- Specific signaling pathways are implicated in muscle wasting during critical illness.
- Early and recovery stages exhibit distinct changes in muscle characteristics.
Conclusions:
- Understanding muscle wasting mechanisms is crucial for developing targeted therapies.
- Novel pharmacologic and nonpharmacologic strategies can potentially prevent or treat muscle wasting.
- Interventions aimed at muscle morphology, protein turnover, and signaling pathways are promising.
Related Concept Videos
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Skeletal Muscle Relaxants: Therapeutic Uses
Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Muscle Recovery and Fatigue
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...

